Cefixime dispersible tablets formulation

Cefixime dispersible tablets formulation

Find patient medical information for Cefixime (Suprax) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings Cefixime is a broad spectrum cephalosporin antibiotic and is commonly used to treat bacterial infections of the ear, urinary tract, and upper respiratory tract. Cefixime is used to treat bacterial infections in many different parts of the body. It belongs to the class of medicines known as cephalosporin antibiotics. It works by killing bacteria or preventing their growth. However, this medicine will not work for colds, flu, or other virus infections. Medscape - Indication-specific dosing for Suprax (cefixime), frequency-based adverse effects, comprehensive interactions, contrain dications, pregnancy & lactation schedules, and cost information. Cefixime is a prescription medication used to treat many different types of infections caused by bacteria. Learn about side effects, dosages, drug interactions, and more. Suprax (cefixime) is an antibiotic prescribed for the treatment of bacterial infections such as sore throat, ear infection, tonsillitis, laryngitis, pneumonia, bronchitis, UTI, COPD, and gonorrhea. Read about side effects, dosages, and more. Learn about cefixime (Suprax) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives. Cefixime is a third generation cephalosporin used to treat susceptible Gram-negative and Gram-positive bacterial infections. Cefixime is an antibiotic that may be used to treat many different types of infections caused by bacteria. Cefixime stops bacteria from forming a cell wall, which bacteria need to survive. Detailed Cefixime dosage information for adults and children. Includes dosages for Bacterial Infection, Urinary Tract Infection, Bronchitis and more; plus renal, liver and dialysis adjustments.

Leave a Reply

Your email address will not be published. Required fields are marked *

*
*